Skip to main content

An official website of the United States government

You have 2 new alerts

TECHNOLOGY TRANSFER OPPORTUNITY: Portable Medical Diagnosis Instrument (TOP2-246)

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Mar 15, 2022 10:35 am EDT
  • Original Response Date: Mar 15, 2023 05:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date:
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: 9999 - MISCELLANEOUS ITEMS
  • NAICS Code:
    • 927110 - Space Research and Technology
  • Place of Performance:

Description

NASA’s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses.

THE TECHNOLOGY:

NASA has developed a novel technology strategy called "The NASA Analyzer" that would provide comprehensive in-flight medical diagnostic capability in a compact, hand-held device for human deep-space missions such as Mars. Key features of the technology include the ability to handle multiple sample types (breath, saliva, blood), and the ability to measure virtually any analyte, including future analytes as they emerge. The device provides both non-invasive and minimally invasive sampling capabilities, which will be required during long-duration exploration missions. Breath and saliva are fully non-invasive and can provide critical health assessment information very rapidly. From small blood samples, information about macromolecular analytes as well as blood cell counts can be obtained. The device consists of four cutting-edge technologies integrated into a single compact medical diagnostic tool with wireless (e.g., smart phone) capability. In addition to space applications, this innovative technology will very likely have important spin-offs in medicine and public health on Earth.

To express interest in this opportunity, please submit a license application through NASA’s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/TOP2-246

If you have any questions, please e-mail NASA’s Technology Transfer Program at Agency-Patent-Licensing@mail.nasa.gov with the title of this Technology Transfer Opportunity as listed in this SAM.gov notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit the NASA Technology Transfer Portal at https://technology.nasa.gov/

These responses are provided to members of NASA’s Technology Transfer Program for the purpose of promoting public awareness of NASA-developed technology products, and conducting preliminary market research to determine public interest in and potential for future licensing opportunities. No follow-on procurement is expected to result from responses to this Notice.

Contact Information

Contracting Office Address

  • WASHINGTON DC 20546-0001
  • WASHINGTON , DC 20546
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • Mar 30, 2023 11:59 pm EDTSpecial Notice (Original)